Market Overview
The market encompasses milk-based, blood-based and urine-based pregnancy detection kits, as well as ultrasound-based and other instrument-aided tests used across livestock and companion animals. Valued at approximately $8.33 billion in 2025, it is projected to grow at a compound annual rate of around 6.8%, reaching roughly $12-13 billion by 2030 depending on the forecast horizon. Demand is supported by the need to improve herd fertility, shorten calving intervals and confirm gestation early in breeding cycles.
- •Estimated 2025 market value: ~$8.33 billion; CAGR of about 6.8% through the late 2020s
- •Core product categories include milk-based, blood-based, urine-based and ultrasound pregnancy tests
- •Primary end users are dairy and beef operations, swine and equine breeders, veterinarians and pet owners
Growth Drivers
Rising global consumption of animal protein is pushing livestock producers to optimize reproductive efficiency, which directly increases kit uptake. Companion animal ownership and per-pet veterinary spending continue to climb in developed economies, broadening demand for in-clinic and at-home pregnancy tests. Technological improvements, including higher-sensitivity immunoassays and portable ultrasound devices, are making pregnancy detection faster, easier and more accurate at the point of use.
- •Expansion of commercial dairy, beef and swine herds is driving systematic pregnancy testing programs
- •Growing companion animal population and willingness to spend on reproductive care supports the pet segment
- •Advances in lateral-flow, ELISA and portable ultrasound technologies improve accuracy and convenience
Segmentation and Regional Analysis
By animal type, livestock (cattle, swine, sheep, goats and horses) accounts for the dominant share because of herd-scale testing, while companion animals form the fastest-growing segment in urbanized markets. By test type, milk-based kits lead in dairy operations, blood-based tests are common in clinical practice, and urine-based and ultrasound devices serve mixed species. North America and Europe lead revenue share today, while Asia-Pacific, led by China and India, and parts of Latin America are posting the fastest growth as dairy and pork industries modernize.
- •Livestock dominates volume; companion animals are the fastest-growing animal-type segment
- •North America and Europe hold the largest revenue shares; Asia-Pacific is the fastest-growing region
- •Milk-based tests lead dairy use; blood-based and ultrasound devices serve broader species and clinical settings
Trends and Outlook
What are the recent trends and outlook?
The next phase of growth will be shaped by the move toward digital, connected diagnostics, including smartphone-linked readers and cloud-based recordkeeping for herd reproductive data. Ultrasound-based and biomarker-driven kits are gaining share as producers seek earlier and more reliable detection. With sustained 6-7% annual growth expected, the market outlook is favorable, particularly in emerging dairy regions and in the premium companion-animal segment.
- •Digital and smartphone-connected pregnancy test readers are an emerging product direction
- •Earlier-gestation biomarker assays and portable ultrasound devices are gaining share
- •Emerging markets in Asia-Pacific and Latin America are expected to deliver the highest incremental growth
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.